Posts

Posted on

Utz Brands To Acquire Insignia Portfolio Company Truco Enterprises

PR Newswire

WALNUT CREEK, Calif., Nov. 12, 2020 /PRNewswire/ — Insignia Capital Group today announced that it has entered into a definitive agreement to sell Truco Enterprises (“Truco” or the “Company”), a leading maker of tortilla chips, salsa and queso sold under the On The Border® (“OTB”) brand, to Utz Brands (NYSE: UTZ) for a total purchase price of $480 million. The deal is expected to close in December 2020 and is subject to customary closing conditions including the receipt of regulatory approvals.

Insignia Capital Group invested in Truco in 2014 to help the Company expand its distribution footprint and launch new product innovation. Together, Insignia and Truco made significant investments in sales and R&D that tripled adjusted EBITDA over the past six years. “It has been a true pleasure partnering with the Truco team to generate this exceptional outcome for all of the Company’s stakeholders,” said David Lowe, CEO of Insignia Capital Group.  “We believe Utz will be an exceptional steward of the brand as Truco executes on its next phase of growth.”

“The Truco team is thrilled to be joining the Utz family of brands, and we are thankful to our partners at Insignia Capital for all of their support”, said Truco CEO Shane Chambers.  “On The Border is now one of the fastest growing Tortilla chip brands and the fastest growing dip brand in the category.  Utz will be able to leverage its world class Direct Store Delivery network to help expand our brand into new markets.  As a result, more consumers across the U.S will have access to our delicious, high quality tortilla chips and dips.  I’m looking forward to working with Dylan and the rest of the Utz senior management team to continue our excellent growth trajectory.”

Harris Williams & Co. is acting as exclusive financial advisor and Kirkland & Ellis LLP is acting as legal counsel to Truco Enterprises and Insignia Capital Group. Goldman Sachs is acting as lead financial advisor to Utz Brands, Bank of America is acting as financial advisor, and Cozen O’Connor is serving as legal counsel to Utz Brands, Inc.

About Truco Enterprises
Truco is a leading developer and marketer of tortilla chips, salsa, and queso under the On The Border® brand. The Company’s products are sold nationally through grocery retailers, club stores, and mass merchandisers. Truco Enterprises is the exclusive licensee of the On The Border brand for food products sold through retail. For more information, please visit www.ontheborderchips.com. Truco Enterprises is a portfolio company of Insignia Capital Group.

About Insignia Capital Group
Insignia Capital Group is a San Francisco Bay Area private equity firm focused on middle-market companies. Insignia partners with company founders and management teams to help drive growth and achieve true business potential. The firm’s principals have significant experience building businesses across the consumer and business services sectors.  For more information, visit www.insigniacap.com.

Cision View original content:http://www.prnewswire.com/news-releases/utz-brands-to-acquire-insignia-portfolio-company-truco-enterprises-301171921.html

SOURCE Insignia Capital Group; Truco Enterprises

Posted on

IIROC Trade Resumption – DND

Canada NewsWire

TORONTO, Nov. 12, 2020 /CNW/ – Trading resumes in:

Company: Dye & Durham Limited

TSX Symbol: DND

All Issues: Yes

Resumption (ET): 8:00 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Posted on

Trend Micro Reports Continued Success for Q3 2020

Despite continued global economic impact of COVID-19 third quarter remains on path with strong SaaS customer growth

PR Newswire

TOKYO, Nov. 12, 2020 /PRNewswire/ — Trend Micro Incorporated (TYO: 4704;TSE: 4704), a global leader in cybersecurity solutions, today announced earnings results for the third quarter of fiscal year 2020, ending September 30, 2020.

The third quarter of 2020 further confirmed the steady increase in digital transformation efforts across consumer, small & medium business and enterprise segments, validating Trend Micro’s strategy and investment in cloud and hybrid cloud security and its focus on delivering rapid innovation via Security-as-a-Service (SaaS). Customers’ need to secure cloud-based applications and infrastructure has resulted in a 74% increase of SaaS-based deployed instances.  

“With the majority of enterprises accelerating their digital transformation to remain competitive in a fast-paced global economy, or shifting to remote work as a result of Covid-19, the attack areas for cybercriminals expand daily. More than ever companies are looking for trusted help with cloud security initiatives. Trend Micro has continued to showcase its dedication and innovation in cloud that began over a decade ago, and we’re pleased to see rapid adoption of our new cloud security services platform amongst customers in both AWS and Azure environments,” said Eva Chen, co-founder and chief executive officer for Trend Micro. “We also recognize the importance of gaining visibility across the extended enterprise that now includes the cloud, and enabling customers to detect and respond to threats faster than ever. With our latest XDR and Managed XDR offerings, we are harnessing the power of the cloud to deliver meaningful and actionable insights so that customers can act quickly and remain resilient.”

For this quarter, Trend Micro posted consolidated net sales of 43,217 million Yen (or US $406 million, 106.22 JPY = 1USD). The company posted operating income of 7,488 million Yen (or US $70 million) and net income attributable to owners of the parent of 3,855 million Yen (or US $36 million) for the quarter.

Key business updates in Q3

Clear leadership and product innovation in cloud security:

Trend Micro kicked-off the quarter announcing its Trend Micro Cloud One™ – Conformity offering is now available to Azure customers, helping global organizations tackle misconfigurations, compliance challenges and cyber-risks in the cloud. The company also achieved the CIS Microsoft Azure Foundation Security Benchmark. Trend Micro Cloud One – Conformity identifies around 230 million cloud misconfigurations for its global Azure and AWS customers every single day.

Trend Micro continues to enhance and improve its leading cloud solutions, unveiling enhanced agility and automation in cloud security through integrations with Amazon Web Services (AWS). As a result, Trend Micro delivers flexible and scalable all-in-one security that helps DevOps engineers securely build and innovate as they migrate to and build in the cloud.

Trend Micro announced that its hybrid cloud security offerings have received the AWS Outposts Ready designation, part of the Amazon Web Services (AWS) Service Ready Program. This designation recognizes that Trend Micro has demonstrated successful integration with AWS Outposts deployments. Achieving the AWS Outposts Ready designation differentiates Trend Micro as an AWS Partner Network (APN) member with products fully tested on AWS Outposts.

Expanding on a strategic relationship from last year, this quarter Trend Micro announced plans for a new, co-developed solution with Snyk, the leader in developer-first open source security. The joint solution will help security teams manage the risk of open source vulnerabilities from the moment open source code is introduced without interrupting the software delivery process. It will be available as part of the Trend Micro Cloud One platform.

In terms of its groundbreaking research, Trend Micro released “Commodified Cybercrime Infrastructure: Exploring the Underground Services Market for Cybercriminals.” This research stated organizations’ on-premise and cloud-based servers are compromised, abused and rented out as part of a sophisticated criminal monetization lifecycle.

Leader
in
Extended
 Detection and Response:
Trend Micro shared the significant business value driven by cloud-powered XDR and Managed XDR offerings, which optimize threat detection and response across all critical vectors. Trend Micro’s XDR solution is both a SaaS-based offering as well as a managed service with the “X” referring to the most extensive sets of data from more protection points, which is critical to find hidden threats. Trend Micro was recently named a Leader in enterprise detection and response by Forrester and achieved the highest initial detection in the MITRE ATT&CK® Framework.

The availability of Worry-Free XDR: a new version of its industry leading XDR platform designed to extend the power of correlated detection and response beyond the endpoint for smaller businesses, was also announced this quarter. This unmatched channel offering is available now as a standalone or managed solution tailored for small and medium businesses (SMBs).

Corporate initiatives to boost organizations’ cybersecurity talent:

Trend Micro also announced its 6th annual Capture the Flag (CTF) Competition, which provides hands on experience to nurture the talent of more cybersecurity professionals. The Trend Micro CTF 2020 – Raimund Genes Cup will be run as a fully online event for the first time, including virtual qualifying and final rounds. This year, the event will include challenges in reverse engineering, forensics/exploitation, open source intelligence (OSINT), mobile, IoT, machine learning, and radio-frequency (RF) systems. RF is featured for the first time after a highly successful engagement with the cybersecurity community in separate Capture the Signal events over the past two years.

Trend Micro announced a new initiative in its long-running effort to close the diversity and talent gap in the technology industry. The company has extended its partnership with Girls in Tech, a global nonprofit bringing the world together through education and experiences. As part of this expanded partnership with Girls in Tech, Trend Micro developed a new Cybersecurity Fundamentals course for the non-profit.

Executive and Enterprise Industry Recognition:
This quarter Trend Micro was recognized with multiple awards for both its leadership team and its dedication to the vulnerability market.


  • CRN
    ®, named Trend Micro co-founder and CEO Eva Chen to its 2020 list of Top 100 Executives.
  • Eva Chen was also recognized as one of the most influential women in the cybersecurity industry on Cyber Defense Magazine‘s Top 100 Women in Cybersecurity for 2020 list.
  • A new report by Omdia, “Quantifying the Public Vulnerability Market,” found that Trend Micro’s Zero Day Initiative (ZDI) disclosed the most vulnerabilities in 2019. This independent research group analyzed disclosures from 11 vulnerability research vendors, with the ZDI maintaining its position as the world’s largest vendor-agnostic bug bounty program for the 10th year in a row.

This quarter marked the 15-year celebration of the ZDI program. Since its inception in 2005, the ZDI has reported more than 7,500 flaws to affected vendors by financially incentivizing the security research community to find bugs before malicious third parties potentially discover them. ZDI has also paid more than $25 million to over 10,000 researchers globally during that time.

Maintaining Leadership in IIoT & Delivering World Leading Research:
In addition to its growing cloud momentum, Trend Micro also continued its Industrial IoT research including the new report “Caught in the Crossfire: Defending Devices From Battling Botnets” warning consumers of a major new wave of attacks attempting to compromise their home routers for use in IoT botnets. The report urges users to take action to stop their devices from enabling this criminal activity.

Trend Micro also announced new research, “Unveiling the Hidden Risks of Industrial Automation Programming” focused on design flaws in legacy languages and released new secure coding guidelines. These are designed to help Industry 4.0 developers greatly reduce the software attack surface, and therefore decrease business disruption in operational technology (OT) environments.

This quarter the company also revealed “Lost in Translation: When Industrial Protocol Translation goes Wrong,” reporting a new class of security vulnerabilities in protocol gateway devices that could expose Industry 4.0 environments to critical attacks. Also known as protocol translators, protocol gateways allow machinery, sensors, actuators and computers that operate in industrial facilities to talk to each other and to IT systems that are increasingly connected to such environments.

As part of its annual mid-year roundup report, Trend Micro also revealed COVID-19 related threats as the single largest type of threat in the first half of the year. In just six months, Trend Micro blocked 8.8 million COVID-19 related threats, nearly 92% of which were email-based.

New patents filed:
Trend Micro was awarded the following patents in Q3 2020:


Patent No.


Issue Date


Title

10728268

7/27/2020

Methods and Apparatus for Intrusion Prevention Using Global and Local Feature Extraction Contexts

10757029

8/25/2020

Network traffic pattern-based machine-readable instruction identification

10754951

8/25/2020

Dynamic Evaluation of Executable Files in a Lightweight Executor

10771620

9/8/2020

Virtualization of smartphone functions in a virtual reality application

Notice Regarding Forward-Looking Statements
Certain statements that are made in this release are forward-looking statements. These forward-looking statements are based on management’s current assumptions and beliefs in light of the information currently available, but involve known and unknown risks and uncertainties. Many important factors could cause actual results to differ materially from those expressed in forward-looking statements. These factors include:

  • Difficulties in addressing new threats and other computer security problems
  • Timing of new product introductions and lack of market acceptance for new
  • products
  • The level of continuing demand for, and timing of sales of, existing products
  • Rapid technological change within the security software industry
  • Changes in customer needs for security software
  • Existing products and new product introductions by competitors and pricing of
  • those products
  • Declining prices for products and services
  • The effect of future acquisitions on our financial condition and results of operations
  • The effect of adverse economic trends on principal markets
  • The effect of foreign exchange fluctuations on our results of operations
  • An increase in the incidence of product returns
  • The potential lack of attractive investment targets and
  • Difficulties in successfully executing our investment strategy
  • New and potentially unforeseen risks and liabilities associated with the internet of
  • things, the use of artificial intelligence in our products and services, and other
  • emerging technologies

About Trend Micro
Trend Micro, a global leader in cybersecurity, helps make the world safe for exchanging digital information. Leveraging over 30 years of security expertise, global threat research, and continuous innovation, Trend Micro enables resilience for businesses, governments, and consumers with connected solutions across cloud workloads, endpoints, email, IIoT, and networks. Our XGen™ security strategy powers our solutions with a cross-generational blend of threat-defense techniques that are optimized for key environments and leverage shared threat intelligence for better, faster protection. With over 6,700 employees in 65 countries, and the world’s most advanced global threat research and intelligence, Trend Micro enables organizations to secure their connected world. www.trendmicro.com

Cision View original content:http://www.prnewswire.com/news-releases/trend-micro-reports-continued-success-for-q3-2020-301171197.html

SOURCE Trend Micro Incorporated

Posted on

Whirlpool Brand Has Highest Ranked Front-Load Washing Machines In 2020 J.D. Power Customer Satisfaction*

PR Newswire

BENTON HARBOR, Mich., Nov. 12, 2020 /PRNewswire/ — This year has given us all an appreciation for the brands and products that consumers can depend on. If you’re looking for appliances that help you knock more off your to-do list, we found the perfect laundry pair. Whirlpool brand designs innovative products that help consumers manage everyday chores with ease, while providing great value, excellent performance and reliability. These attributes have been recognized by J.D. Power, who has awarded Whirlpool brand the top-ranking scores across four categories for its front-load washing machines:

  • Ease of use
  • Performance and Reliability
  • Warranty
  • Price

The combination of these qualities has earned Whirlpool brand front-load washers the highest rank for customer satisfaction in the J.D. Power 2020 Laundry Appliances Satisfaction Study, now in its 16th year. 

“At Whirlpool brand, we know our appliances deliver high-performance, reliable, easy to use features that are cost-effective, because we work really hard to ensure they do,” said Nelly Martinez, senior brand manager for Whirlpool brand. “When that message is reinforced independently by J.D. Power, a trusted leader in tracking consumer preferences, it’s an honor and a testament to the innovation we put behind our products.” Ms. Martinez goes on to say, “Making a difference in people’s lives by creating trustworthy laundry appliances is a great source of pride to us at Whirlpool brand. It’s what we thrive on, and we’re proud to see that our achievements are acknowledged by J.D. Power and consumers alike.”

As the trusted symbol of the Voice of the Customer, the J.D. Power customer satisfaction awards ensure that the highest-performing brands and products stand out in a crowd. The 2020 Laundry Appliance Satisfaction Study is based on more than 2,000 evaluations from customers who purchased laundry washers and more than 1,600 evaluations from customers who purchased laundry dryers during the past 12 months. The study was fielded from January through March 2020.

To learn more about Whirlpool’s award-winning lineup of front load washing machines and to shop the latest innovations, visit https://www.whirlpool.com/laundry/front-load-washer-set.html

*Recognition is in a tie with another appliance.

About Whirlpool Brand (NYSE: WHR)
For more than one hundred years, Whirlpool brand has been inspired by how people care for their families. Whirlpool brand is designing home appliances that are focused on improving how families give and get the care they need with the latest technologies and innovations – whether that means most flexible refrigerator storage for all types of family needs, induction technology for efficient cooking and easier cleaning, or laundry pairs that sense and adapt to clothes with the latest in connected technologies. Whirlpool brand created and continues outpacing goals of its Care Counts™ Laundry Program, through which the brand is committed to helping create educational equality by installing washers and dryers in schools to help remove one small but important barrier to attendance – access to clean clothes. Whirlpool brand is part of Whirlpool Corporation, the world’s leading manufacturer and marketer of major home appliances. For more information on Whirlpool, please visit whirlpool.com/everydaycare or find us on Facebook at facebook.com/whirlpoolusa or Twitter at @WhirlpoolUSA. Additional information about the company can be found at whirlpoolcorp.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/whirlpool-brand-has-highest-ranked-front-load-washing-machines-in-2020-jd-power-customer-satisfaction-301170353.html

SOURCE Whirlpool Corporation

Posted on

Medicago and GSK Announce Start of Phase 2/3 Clinical Trials of Adjuvanted COVID-19 Vaccine Candidate

Medicago and GSK Announce Start of Phase 2/3 Clinical Trials of Adjuvanted COVID-19 Vaccine Candidate

The COVID-19 vaccine candidate will contain GSK’s pandemic adjuvant

Phase 3 part of clinical trial to enroll up to 30,000 volunteers worldwide

QUEBEC CITY, Quebec & LONDON–(BUSINESS WIRE)–
Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK are pleased to announce the start of Phase 2/3 clinical trials of its plant-derived vaccine candidate for COVID-19 to evaluate its efficacy, safety, and immunogenicity. Based on the positive Phase 1 results and the approval of Canadian regulatory authorities, Medicago has decided to launch the Phase 2/3 clinical trial with GSK’s pandemic adjuvant.

“Our Phase 1 results of the adjuvanted vaccine candidate were very encouraging and fully support further clinical evaluation,” said Nathalie Landry, Executive Vice President, Scientific and Medical Affairs at Medicago.

Thomas Breuer, Chief Medical Officer GSK Vaccines said “This is the first of several GSK COVID-19 vaccine candidate collaborations to start Phase 2/3 clinical testing and an important step forward in our contribution to the global fight against the pandemic. We are delighted with the very promising Phase 1 results of Medicago’s COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant. Proven dose-sparing and a high immune response due to GSK’s adjuvant make us confident of delivering an efficacious vaccine with an acceptable safety profile in collaboration with Medicago.”

The Coronavirus-Like Particle COVID-19 vaccine candidate (CoVLP) is composed of recombinant spike (S) glycoprotein expressed as virus-like particles (VLPs).

The study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP (two doses of 3.75 µg CoVLP combined with GSK’s pandemic adjuvant given 21 days apart) has an acceptable immunogenicity and safety profile in healthy adults 18-64 years of age and in elderly subjects aged 65 and over.

The Phase 2 trial part is a randomized, observer-blind, placebo-controlled study to evaluate the safety and immunogenicity of the adjuvanted recombinant COVID-19 plant-derived vaccine candidate in subjects aged 18 and above. It will be conducted in multiple sites in Canada and, upon FDA allowance, in the United States and on a population composed of healthy adults (18-64y) and elderly adults (over 65y). Each age group will have over 300 subjects randomized 5:1 to receive the adjuvanted CoVLP vaccine candidate: placebo and with 2:1 stratification in older adults (65-74 and ≥75). All subjects will be followed for a period of 12 months after the last vaccination for the assessment of safety and durability of the immune responses to the vaccine candidate.

The Phase 3 part of the study should start before the end of 2020 and is an event-driven, randomized, observer-blinded, placebo-controlled design that will evaluate the efficacy and safety of the CoVLP formulation, compared to placebo, in up to 30,000 subjects in North America, Latin America and/or Europe and within the same population, or – alternatively – amongst a broader one pending approval by regulatory authorities.

About Medicago

Medicago is a biopharmaceutical company and pioneer in plant-derived therapeutics. Founded in 1999 with the belief that innovative approaches and rigorous research would bring new solutions in healthcare.

Our mission is to improve global health outcomes by leveraging innovative plant-based technologies for rapid responses to emerging global healthcare challenges. Medicago is committed to advancing therapeutics against life-threatening diseases worldwide. Our team includes over 450 scientific experts and employees in Canada and the United States and academic affiliations in Europe and South Africa.

Medicago has previously demonstrated its capability to be a first responder in a flu pandemic. In 2009, the company produced a research-grade vaccine candidate against H1N1 in just 19 days. In 2012, Medicago manufactured 10 million doses of a monovalent influenza vaccine candidate within one month for the Defense Advanced Research Projects Agency (DARPA), part of the U.S. Department of Defense. In 2015, Medicago also demonstrated in principle that it could rapidly produce an anti-Ebola monoclonal antibody cocktail for the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services.

For more information:www.medicago.com

To learn more about our plant-based technology: Video / Website

About GSK and its commitment to tackling COVID-19

GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. For further information please visit www.gsk.com/about-us.

GSK is collaborating with companies and research groups across the world working on promising COVID-19 vaccine candidates through the use of our innovative vaccine adjuvant technology. The use of an adjuvant is of particular importance in a pandemic situation since it may reduce the amount of vaccine protein required per dose, allowing more vaccine doses to be produced and therefore contributing to protecting more people. GSK does not expect to profit from COVID-19 vaccines during the pandemic phase, and will invest any short-term profit in coronavirus related research and long-term pandemic preparedness, either through GSK internal investments or with external partners.

Medicago Media contact (English):

Alissa Von Bargen

+1-647-234-5975

[email protected]

Medicago Media contact (French):

Marie-Pier Côté

+ 1-418-999-4847

[email protected]

GSK enquiries:

Media enquiries:

Simon Steel, +44 (0) 20 8047 5502 (London)

Simon Moore, +44 (0) 20 8047 5502 (London)

Kathleen Quinn, +1 202 603 5003 (Washington DC)

Analyst/Investor enquiries:

Sarah Elton-Farr, +44 (0) 20 8047 5194 (London)

James Dodwell, +44 (0) 20 8047 2406 (London)

Jeff McLaughlin, +1 215 751 7002 (Philadelphia)

KEYWORDS: Europe United Kingdom North America Canada

INDUSTRY KEYWORDS: Biotechnology Infectious Diseases Health Pharmaceutical Clinical Trials

MEDIA:

Posted on

Northwell Health partners with TeleTracking to bring real-time bed visibility to New York health system

Pittsburgh, PA, Nov. 12, 2020 (GLOBE NEWSWIRE) — Northwell Health, the largest healthcare provider in New York state, signed an extended agreement with TeleTracking Technologies, Inc., the capacity management and health system command center technology pioneer, to centralize operations and bring real-time bed visibility to the system’s 19 facilities.

For nearly three decades, TeleTracking has delivered enterprise technology to hundreds of health systems across the U.S., Canada and UK, providing real-time, actionable and meaningful data to make better, faster and safer decisions about patient care.

Northwell Health was squarely in the epicenter of the COVID-19 crisis that unfolded across greater New York City this past spring. The ability to effectively coordinate day-to-day activities and respond to the dynamic needs of patients, staff and the community quickly emerged as a critical need. Northwell Health’s success in mobilizing resources for the first wave of COVID-19 resulted in the creation of strong resurgence plans if a second wave emerges. In addition, as part of Governor Cuomo’s “build back better” plan, Michael Dowling, President and CEO of Northwell Health, has been tasked to lead the effort to institutionalize hospitals to operate as one system in a public health emergency.

“We have been honored to work closely with Northwell Health for a number of years and serve as a trusted partner as their enterprise vision has evolved,” says Chris Johnson, President, TeleTracking. “We worked tirelessly prior to the pandemic to help the system map long-term patient flow objectives, including aligning clinical and executive stakeholders. When COVID-19 struck, TeleTracking quickly mobilized to help manage patient logistics across the system by adding and tracking surge beds in areas like PACUs, catheterization labs, cafeterias, and other spaces across acute care locations.”

The extension of this agreement will allow Northwell Health to now see all available beds across the system. The data generated by TeleTracking will ensure more timely bed turnover processes to reduce patient delays, holds and length of stay associated with the discharge process; automate workflows and improve communications; expedite access to the right level of care; and identify and eliminate patient flow bottlenecks.

“TeleTracking’s contributions go well beyond technology. Our advisory services and client transformation teams have worked diligently to establish strong clinical workflows and continuity without disrupting operations,” adds Maria Romano, Clinical Advisor, TeleTracking.

The comprehensive, enterprise view of bed capacity across all 19 Northwell Health sites will allow the system to meet their community responsibilities and fulfill their mission.

“We consider TeleTracking more than a vendor. Every member of their team is a partner who shares our values and strategic vision to serve the people of New York and provide access to exceptional care,” concludes John D’Angelo, MD, Senior Vice President and Executive Director, Emergency Medicine Services, Northwell Health.

About TeleTracking Technologies, Inc.

For every hour patients wait for care, they face objectively worse outcomes. TeleTracking believes it is unacceptable that patients are not able to access the care they need, when they need it, due to operating inefficiencies and unnecessary cost barriers. Our mission is simple, to ensure no one waits for the care they need. And that’s why more than a decade ago, TeleTracking recognized the significant benefits of a centralized approach to managing patient flow and has implemented more than one hundred health system command centers across the United States and United Kingdom. TeleTracking has delivered extraordinary outcomes for nearly three decades that have been the subject of study by KLAS, Gartner and the RAND Corporation.

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals and nearly 800 outpatient facilities. We care for more than two million people annually in the metro New York area and beyond, thanks to philanthropic support from our communities. Our 74,000 employees—17,000-plus nurses and about 4,500 physicians, including more than 3,300 members of Northwell Health Physician Partners—are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes. We’re training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the School of Nursing and Physician Assistant Studies.

Amie Podolak
TeleTracking Technologies, Inc.
412-736-9399
[email protected]

Posted on

Arcadia Biosciences (RKDA) Announces a Series of Strategic Transactions with Bioceres Crop Solutions (BIOX)

— Arcadia receives a total of $8 million in up-front and contingent cash and 1.875 million BIOX shares —

— Arcadia sells its interest in Verdeca to Bioceres and will receive future trait royalties up to $10 million on HB4® soybean sales —

— Arcadia licenses GoodWheat™ to Bioceres in South and Central America and will receive future royalties on all GoodWheat sales —

PR Newswire

DAVIS, Calif., Nov. 12, 2020 /PRNewswire/ — Arcadia Biosciences, Inc. (Nasdaq: RKDA) today announced a series of strategic transactions with Bioceres Crop Solutions Corp (NYSE: BIOX), including the sale of its membership interest in Verdeca, a soybean joint venture the two companies formed in 2012. In another transaction, Bioceres acquired license rights to Arcadia’s GoodWheat™ technologies in South and Central America.

Under the terms of the agreement, Arcadia will receive $6 million in cash, including reimbursement of transaction related expenses and fees, with an additional $2 million in cash to be paid upon achievement by Verdeca of specific regulatory and commercial milestones. Arcadia also receives 1.875 million unregistered shares of BIOX common stock and a royalty stream up to $10 million on HB4® soybean sales.

“For more than a half-dozen years, we’ve successfully collaborated with Bioceres through our Verdeca joint venture to combine our capabilities in plant genomics, product development and global crop deregulation to bring the first drought tolerant, herbicide resistant product – HB4 soybeans – to market,” said Matthew Plavan, president and CEO of Arcadia Biosciences. “We believe it’s time now to consolidate the commercial leadership of the HB4 program under Bioceres, with its strong reputation and footprint in South American agriculture, the primary target market for HB4 soybeans.”

“Receiving a sizable stake in Bioceres and ongoing HB4 royalty revenue allows Arcadia to continue sharing in the HB4 opportunity, while the cash component of the transaction further strengthens our balance sheet,” Plavan continued. “At the same time, turning over the reins to our trusted partner to consolidate critical decision making and execution enables greater agility for forward commercialization of Verdeca’s pipeline.” 

“Verdeca has been a truly successful venture between our two companies,” said Federico Trucco, chief executive officer of Bioceres Crop Solutions. “However, as we enter the HB4 commercial phase, we and our Arcadia partners agree that the joint venture is no longer an optimal structure. Therefore, we opted to acquire 100 percent ownership of Verdeca, while at the same time welcoming Arcadia as a BIOX shareholder.”

As part of the strategic transaction, Bioceres also acquired license rights to Arcadia’s GoodWheat portfolio of branded non-GMO specialty wheat products in South and Central America, along with Arcadia’s specialty safflower oil assets.

“South and Central America are important wheat markets for our GoodWheat products,” continued Plavan. “Bioceres is the ideal partner to represent our brand, as we seek to leverage their deep network of production and commercial partners together with their integrated product offerings in crop nutrition and crop protection.”

“We are very pleased to collaborate with Arcadia on its GoodWheat platform,” added Trucco. “We have followed the development and initial market reception of the GoodWheat portfolio of products in the United States and are eager to be the first to bring these high-value products to South and Central America, where we expect the grower demand to be strong and the food ingredient applications to be broad.” 

Rabobank acted as financial advisor to Arcadia Biosciences for the transactions.

About Arcadia Biosciences, Inc.
Arcadia Biosciences (Nasdaq: RKDA) is a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients. The company’s GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. The company’s GoodHemp™ seed catalog delivers genetically superior hemp seeds and clones, applying the company’s proprietary crop innovation technology, ArcaTech™, to an emerging crop. Arcadia’s agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. For more information, visit www.arcadiabio.com. 

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. (NYSE American: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4® program, the company is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, visit https://investors.biocerescrops.com.

About Verdeca
Verdeca, a U.S.-based joint venture between Bioceres Crop Solutions and Arcadia Biosciences, develops and deregulates soybean varieties with next-generation agricultural technologies. Working in partnership with South American growers, Verdeca aims to provide technologies that help increase crop productivity, making more efficient and sustainable use of land and water resources. For more information visit www.verdeca.com.

Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: Arcadia’s, Bioceres’, Verdeca’s and their partners’ and affiliates’ ability to develop and commercialize products incorporating their traits, and complete the regulatory review process for such products, including obtaining approval from China; Bioceres’ compliance with laws and regulations that impact Verdeca’s business, and changes to such laws and regulations; Verdeca’s future capital requirements and ability to satisfy its capital needs; fluctuations in BIOX’s stock price; and the other risks set forth in Arcadia’s and Bioceres’ filings with the Securities and Exchange Commission from time to time, including the risks set forth in Arcadia’s Annual Report on Form 10-K for the year ended December 31, 2019, Bioceres’ Annual Report on Form 20-F for the year ended June 30, 2020, and other filings. These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. and Bioceres Crop Solutions Corp. disclaim any obligation to update these forward-looking statements.

LinkedIn: Arcadia Biosciences

Twitter: @ArcadiaAg

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-announces-a-series-of-strategic-transactions-with-bioceres-crop-solutions-biox-301171794.html

SOURCE Arcadia Biosciences, Inc.

Posted on

RigNet to Present Virtually and Host 1×1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18th and 19th

PR Newswire

HOUSTON, Nov. 12, 2020 /PRNewswire/ — RigNet, Inc. (NASDAQ: RNET) (the “Company”), a leading provider of ultra-secure, intelligent networking solutions and specialized applications, announced that Steven Pickett, President and Chief Executive Officer, and Lee M. Ahlstrom, Senior Vice President and Chief Financial Officer, will participate in the virtual Southwest IDEAS Investor Conference on November 18th and 19th, 2020. RigNet’s company presentation will be webcasted and is scheduled to be available at 7:00 am CST on November 18th. The presentation can be accessed through the Southwest IDEAS conference portal for registered participants on the IDEAS conference website: www.IDEASconferences.com and in the investor relations/presentations section of the Company’s website: http://www.rig.net.

About IDEAS Investor Conferences

The mission of the IDEAS Conferences is to provide independent regional venues for quality companies to present their investment merits to an influential audience of investment professionals.  Unlike traditional bank-sponsored events, IDEAS Investor Conferences are “Sponsored BY the Buyside FOR the Buyside” and for the benefit of regional investment communities.  Conference sponsors collectively have more than $200 billion in assets under management and include: Adirondack Research and Management, Allianz Global Investors: NFJ Investment Group, Ariel Investments, Aristotle Capital Boston, Barrow Hanley Mewhinney & Strauss, BMO Global Asset Management, Constitution Research & Management, Inc., Fidelity Investments, First Wilshire Securities Management, Inc., Gamco Investors, Granahan Investment Management, Great Lakes Advisors, Greenbrier Partners Capital Management, LLC, GRT Capital Partners, LLC, Hodges Capital Management, Ironwood Investment Management, Keeley Teton Advisors, Luther King Capital Management, Marble Harbor Investment Counsel, Perritt Capital Management, Punch & Associates, Westwood Holdings Group, Inc., and William Harris Investors.

The IDEAS Investor Conferences are held annually in Boston, Chicago and Dallas and are produced by Three Part Advisors, LLC.  Additional information about the events can be located at www.IDEASconferences.com.

If interested in participating or learning more about the IDEAS conferences, please contact Lacey Wesley at  (817) 769 -2373 or [email protected].

About RigNet

RigNet (NASDAQ: RNET) delivers advanced software and communications infrastructure that allow our customers to realize the business benefits of digital transformation. With world-class, ultra-secure solutions spanning global IP connectivity, bandwidth-optimized OTT applications, IIoT big data enablement, and industry-leading machine learning analytics, RigNet supports the full evolution of digital enablement, empowering businesses to respond faster to high priority issues, mitigate the risk of operational disruption, and maximize their overall financial performance. RigNet is headquartered in Houston, Texas with operations around the world. 

For more information on RigNet, please visit www.rig.net. RigNet is a registered trademark of RigNet, Inc.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/rignet-to-present-virtually-and-host-1×1-investor-meetings-at-the-annual-southwest-ideas-investor-conference-on-november-18th-and-19th-301171638.html

SOURCE RigNet, Inc.

Posted on

Biocept Provides Update on COVID-19 Testing with More than 100,000 Samples Received

PR Newswire

SAN DIEGO, Nov. 12, 2020 /PRNewswire/ — Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer, announces an update on its COVID-19 testing with more than 100,000 samples received to date for processing through its RT-PCR technology at its CLIA-certified, CAP-accredited high-complexity molecular laboratory. 

“We are providing COVID-19 testing to a growing list of clients including skilled nursing centers, hospitals, clinics and surgery centers.  The majority of our customers are located in California, but we are receiving samples from across the country,” said Michael Nall, President and CEO of Biocept.  “We are committed to providing this important service during the pandemic and we continue to return the vast majority of COVID-19 test results to our customers within 48 hours of receiving a sample.  

“We expect COVID-19 RT-PCR testing will have a significant positive impact on our revenues through the remainder of the year and continuing into 2021,” he added.

About Biocept
Biocept, Inc. is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company uses its proprietary liquid biopsy technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer. The Company’s patented Target Selector™ liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in circulating tumor DNA (ctDNA). With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient’s disease and therapeutic options. Additionally, Biocept is offering nationwide COVID-19 polymerase chain reaction (PCR) testing to support public health efforts during this unprecedented pandemic. For more information, please visit www.biocept.com.

Forward-Looking Statements Disclaimer Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this release are not strictly historical, including without limitation statements regarding our expectation that COVID-19 RT-PCR testing will have a significant positive impact on our revenues through the remainder of the year and continuing into 2021, and the ability of Biocept’s platform to identify cancer mutations and alterations to inform physicians about a patient’s disease and therapeutic options, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our Securities and Exchange Commission (SEC) filings. The effects of such risks and uncertainties could cause actual results to differ materially from the forward-looking statements contained in this release. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this press release except as required by law. Readers are advised to review our filings with the SEC, which can be accessed over the Internet at the SEC’s website located at www.sec.gov.


Investor Contact

:
 

LHA Investor Relations

Jody Cain

[email protected] 
310-691-7100

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biocept-provides-update-on-covid-19-testing-with-more-than-100-000-samples-received-301171466.html

SOURCE Biocept, Inc.

Posted on

Biannual State of the Home Survey Examines Impact of Pandemic on Financial Savings Strategies

Biannual State of the Home Survey Examines Impact of Pandemic on Financial Savings Strategies

NORWALK, Conn.–(BUSINESS WIRE)–
HomeServe USA (HomeServe), a leading provider of home repair solutions, announced the findings of the 11th edition of its Biannual State of the Home Survey. The survey reports on the financial impact of home repairs and the state of the American home. This edition, in light of COVID-19, also looked at whether Americans have changed their financial savings strategy as a result of the pandemic.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201112005174/en/

Infographic on HomeServe's 11th edition of its Biannual State of the Home Survey (Photo: Business Wire)

Infographic on HomeServe’s 11th edition of its Biannual State of the Home Survey (Photo: Business Wire)

“2020 has, without a doubt, been a year of significant turmoil. So for the 11th edition of our survey, we wanted to provide some measurement of the impact uncertainty and the COVID-19 pandemic has had on our lives,” said Tom Rusin, Global CEO of HomeServe Membership. “The survey made it clear that the pandemic has impacted many Americans’ financial savings strategies, with a significant number – 43% – indicating that they are trying to save more for the future than they were prior as a result of COVID-19. This is especially significant coupled with the survey finding that over one-third of homeowners (36%) have less than $500 – or nothing at all – set aside for an emergency home repair, yet 62% of homeowners have had a home repair emergency in the past 12 months.”

This edition of the survey was conducted online by The Harris Poll on behalf of HomeServe, September 16-18, 2020, among 2,053 U.S. adults age 18+, of which 1,424 are homeowners.

Americans’ Savings Practices Now and Post COVID-19

The survey looked at how COVID-19 has impacted Americans’ strategy for saving financially for the future. Forty-three percent of Americans say they are trying to save more for the future than they were before as a result of the pandemic; with 53% of those age 18-36 saying they are trying to save more. On the other side, 13% of Americans say they will likely save less than they were before as a result of COVID-19.

Each of the 11 editions of the survey have measured homeowners’ savings practices for unexpected home emergencies. This edition of the survey found that over one-third (36%) of homeowners have less than $500 or nothing set aside for an emergency home repair. Nearly one in five homeowners (19%) with an annual household income of less than $50,000 reported having no savings set aside for such an emergency. The lack of savings is especially concerning given that more than three out of five (62%) homeowners reported having a home repair emergency in the past 12 months.

Twenty-one percent of homeowners in the Midwest reported having no funds set aside for a home emergency repair, while only 9% of homeowners in the Northeast and West have no savings for such a repair.

Homeowners Tackle Home Repairs and Decorating During COVID-19

It’s not surprising that American homeowners are taking advantage of more time at home during quarantine to make the spaces they live in more enjoyable. Spending more time at home has caused nearly one-third of homeowners (31%) to want to renovate or redecorate their home and one-third (32%) report that it has allowed them to tackle some needed home repairs. This trend is reinforced by the 20% increase in demand for repair services that HomeServe has seen from its customers since the pandemic began.

Additionally, almost one-quarter of Americans (24%) say that more time at home has made them realize how much they love the spaces they live in. On the flip side, 15% of Americans report that spending more time at home during quarantine has made them want to move to a new home with those ages 18-36 being more likely than those ages 37+ to say this (24% vs. 11%).

For more information on available repair service plans, visit www.HomeServeUSA.com and for helpful homeowner tips, visitwww.HomeServeUSA.com/blog.

Survey Methodology

This survey was conducted online within the United States by The Harris Poll on behalf of HomeServe from September 16-18, 2020 among 2,053 U.S. adults ages 18 and older (among whom 1,424 are homeowners). This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact [email protected].

About HomeServe

HomeServe USA Corp. (HomeServe) is a leading provider of home repair solutions serving more than 4.4 million customers across the US and Canada under the HomeServe, Home Emergency Insurance Solutions, Service Line Warranties of America (SLWA), Service Line Warranties of Canada (SLWC) names, and through locally branded HVAC companies located in major metro areas. Since 2003, HomeServe has been protecting homeowners against the expense and inconvenience of water, sewer, electrical, HVAC and other home repair emergencies by providing affordable repair coverage, installations and quality local service.

As an A+ rated Better Business Bureau Accredited Business, HomeServe is dedicated to being a customer-focused company supplying best-in-class repair plans and other services to consumers directly and through over 1,000 leading municipal and utility partners.

HomeServe has teamed up with executive producer, host, and best-selling author Mike Rowe, best known as the creator and host of the hit TV series Dirty Jobs, to work together to provide homeowners expert advice on maintaining, enhancing and protecting their homes. For more information about HomeServe, a Great Place To Work certified winner and recipient of thirty 2020 Stevie Awards for Sales & Customer Service, or to learn more about HomeServe’s affordable repair plans, please go to www.homeserve.com. Connect with HomeServe on Facebook and Twitter @HomeServeUSA. For news and information follow on Twitter @HomeServeUSNews.

Myles Meehan

HomeServe USA

Phone: 203-356-4259

Email: [email protected]

Claire Deneen

Hill+Knowlton Strategies for HomeServe

Phone: 312-255-3134

Email: [email protected]

KEYWORDS: United States North America Connecticut

INDUSTRY KEYWORDS: Professional Services Utilities Residential Building & Real Estate Insurance Energy Construction & Property

MEDIA:

Logo
Logo
Photo
Photo
Infographic on HomeServe’s 11th edition of its Biannual State of the Home Survey (Photo: Business Wire)